check_circleStudy Completed
Contraception
Bayer Identifier:
91309
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
Gravistat 125 Bioequivalenz
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
45 - 75 YearsTrial summary
Enrollment Goal
42Trial Dates
April 2005 - September 2005Phase
Phase 1Could I Receive a placebo
N/AProducts
Estradiol Valerate (EV, DS00124)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bayer Pharma AG | Berlin, 13353, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A